TY  - JOUR
AU  - Nguyen, M
AU  - Jacobson, T
AU  - Torres, J
AU  - Wann, A
Y2  - 2021/08/15
Y1  - 2021/02/26
SN  - 2573-8348
UR  - http://hdl.handle.net/11343/280347
AB  - BACKGROUND: Febrile neutropenia is a serious complication of chemotherapy. The Multinational Association for Supportive Care in Cancer (MASCC) risk index score identifies patients at low risk of serious complications. Outpatient management programs have been successfully piloted in other Australian metropolitan cancer centers. AIM: To assess current management of febrile neutropenia at our regional cancer center and determine potential impacts of an outpatient management program. METHOD: We performed a retrospective review of medical records for all patients admitted at our regional institution with febrile neutropenia between 1 January 2016, and 31 December 2018. We collected information regarding patient characteristics, determined the MASCC risk index score, and if low risk, we determined the eligibility for outpatient care and potential reduction in length of stay and cost benefit. RESULTS: A total of 98 hospital admissions were identified. Of these, 66 had a MASCC low-risk index score. Fifty-eight patients met the eligibility criteria for outpatient management. Seventy-one percent were female. The most common tumor type was breast cancer. Forty-eight percent were treated with curative intent. The median length of stay was 3 days. The median potential reduction in length of stay for each admission was 2 days. The total potential reduction in length of stay was 198 days. No admission resulted in serious complications. CONCLUSION: This review demonstrates a significant number of hospital admission days can be avoided. We intend to conduct a prospective pilot study at our center to institute an outpatient management program for such low-risk patients with potential reduction in hospital length of stay. This will have significant implications on health resource usage, service provision planning, and patient quality of life.
LA  - English
PB  - WILEY
T1  - Potential reduction of hospital stay length with outpatient management of low-risk febrile neutropenia in a regional cancer center
DO  - 10.1002/cnr2.1345
IS  - Cancer Reports
VL  - 4
IS  - 3
L1  - /bitstream/handle/11343/280347/cnr2.1345.pdf?sequence=1&isAllowed=y
ER  -